Why the study?
Catheter ablation for symptomatic non-paroxysmal atrial fibrillation remains challenging, and hybrid ablation requires collaboration to develop workflows and patient selection strategies.
Hybrid ablation requires collaboration between electrophysiologists and cardiac surgeons, and this review provides guidance on patient selection and workflow development.
May guide hybrid convergent AF ablation workflows; leaves open prospective validation of selection criteria.
Catheter ablation for treatment of symptomatic non-paroxysmal atrial fibrillation remains challenging. Clinical failure and need for continued medical therapy or repeat ablation is common, especially in more advanced forms of atrial fibrillation. Hybrid ablation has emerged as a more effective and safe therapy than endocardial-only ablation particularly for longstanding persistent atrial fibrillation as demonstrated by the randomized controlled CONVERGE trial. Hybrid ablation requires collaboration of electrophysiologists and cardiac surgeons to develop specific workflows. This review describes the Hybrid Convergent approach in the context of available ablation options and offers guidance for workflow development and patient selection.
No takes yet. Share an insight, caveat, or question.
David B. De Lurgio (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: